Gastrointestinal Hemorrhage, Volatile Organic Compounds
Conditions
Brief summary
Cross sectional case-control study investigating the difference of volatile organic compound in the exhaled breath of the patients with GI bleeding and normal population.
Detailed description
This study investigates the difference of volatile organic compound in the exhaled breath of the patients with GI bleeding and normal population. We aimed to find out the biomarkers for GI bleeding.
Interventions
Collection of exhaled breath will be analyzed for specific volatile organic compounds which show different distribution between groups
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged between 20 and 80 * Low possibility of gastrointestinal bleeding was proven by esophagogastroduodenoscopy and colonoscopy which were performed within 1 year. * NSAID non-user (within 1 months before the date of inclusion)
Exclusion criteria
* Diagnosis of malignancy diagnosed within 5 years * Past medical history of chronic liver disease, chronic kidney disease, chronic lung disease, chronic bronchial disease, asthma * Surgical history of any kind of gastrectomy * Surgical history of any kind of lung resection which could impact the patient's lung function.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| VOC Patterns | 1 day of 1st emergency room (ER) visit for GI bleeding | Patterns of volatile organic compounds recognized by sensor array |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Measurement of VOC | 1 day of 1st emergency room (ER) visit for GI bleeding | Qualitative and quantitative assay of volatile organic compounds by GC-MS |
| Change of VOC patterns | 2nd visit (about 2weeks apart from 1st visit) | Change of the patterns of volatile organic compounds recognized by sensor array after recovery from GI bleeding |
Countries
South Korea